This is a multiple-award Indefinite Delivery Contract (IDC) with a $80,000,000 ceiling value, awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. Department of Health and Human Services (HHS), to the UK Health Security Agency (formerly Public Health England), a government agency in the United Kingdom. The contract is for the provision of pre-clinical models and services related to infectious disease research and development, including biological...
The National Institute of Allergy and Infectious Diseases (NIAID) has awarded a single-award, $146.3 million Indefinite Delivery Contract (IDC) to The Research Foundation For The State University Of New York to develop and employ animal and animal replacement models of infectious diseases for screening, product evaluation, and eventual clinical evaluation. This IDC contains four task areas:
Task Area A - Small Animal Models of Infectious Diseases
Task Area B - Non-Human Primate Models of...
The National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency of the U.S. Department of Health and Human Services, awarded a $146.3 million Indefinite Delivery Contract (IDC) to Institute For Clinical Pharmacodynamics, Inc., a for-profit organization, to provide pre-clinical models of infectious diseases under Task Area C. The period of performance is from July 15, 2024 to July 14, 2031.
The contract is a follow-on to a previous Preclinical Models of Infectious Diseases...
The federal contract IDV award, valued at up to $146.3 million over a 7-year ordering period, was issued by the National Institute of Allergy and Infectious Diseases (NIAID) to the Ministry of Defence (D S T L) of the United Kingdom. The contract aims to provide a broad range of animal and animal replacement models to evaluate the efficacy of candidate countermeasures, including vaccines, therapeutics, and diagnostics, against infectious agents under NIAID's purview. This includes models for...
This indefinite delivery contract (IDC) was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the Department of Health and Human Services, to the American Foundation For Biological Research, doing business as the Biomedical Research Institute. The $146.3 million single-award IDC has a period of performance from July 15, 2024 to July 14, 2031.
The purpose of this IDC is to provide NIAID with the capability and capacity to develop and employ...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a single-award Indefinite Delivery Contract (IDC) worth up to $146,300,000 to The Johns Hopkins University to provide pre-clinical models of infectious diseases. The contract has a period of performance from July 2024 to July 2031.
The contract encompasses four task areas: (A) Small Animal Models, (B) Non-Human Primate Models, (C) Animal Replacement and Non-Traditional Animal Models, and (D) Generation and Distribution...
The National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services, awarded a single-award Indefinite Delivery Contract valued up to $146,300,000 to Southern Research Institute, a non-profit research organization, to develop and employ animal and animal replacement models of infectious diseases. The contract will support screening, product evaluation, and eventual clinical evaluation of vaccines, therapeutics, and...
This indefinite delivery contract (IDC) was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to The Charles Stark Draper Laboratory, Inc. (Draper) for the development and employment of animal and animal replacement models of infectious diseases. The $146.3 million single-award IDC has a 7-year ordering period and supports the full range of preclinical evaluations, including screening, product evaluation, and eventual clinical evaluation of...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a single-award Indefinite Delivery Contract (IDC) worth up to $146.3M to the University of South Alabama to provide pre-clinical models of infectious diseases. The contract has a 7-year ordering period ending on July 14, 2031.
The IDC comprises four task areas focused on developing and refining small animal, non-human primate, and non-traditional/animal replacement models to evaluate candidate countermeasures (e.g....
The National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services, awarded a $146.3 million single-award Indefinite Delivery Contract (IDC) to the University of Georgia Research Foundation, Inc. (UGA Research Foundation) in July 2024. This 7-year contract focuses on developing and employing animal and animal replacement models to support NIAID's pandemic preparedness efforts. The contract covers four main task areas:...
The National Institute of Allergy and Infectious Diseases (NIAID) has awarded a $146.3 million single-award Indefinite Delivery Contract (IDC) to the UK Health Security Agency (formerly Public Health England) to provide preclinical services in support of the development of medical countermeasures against chemical, biological, radiological, and nuclear threats. The contract includes task areas for small animal models, non-human primate models, animal replacement and non-traditional animal models, and the generation and distribution of specialized research reagents. This IDC will enable NIAID to rapidly evaluate candidate therapeutics, vaccines, and diagnostics targeting priority pathogens, including RNA viruses with pandemic potential, antimicrobial-resistant infections, and neglected tropical diseases. The contract does not utilize any set-aside designations and has a period of performance through July 2031. To date, the agency has issued over $18 million in task orders for animal model development, medical countermeasure testing, and contract management services.